Nexalin technology awarded key patent related to its non-invasive, frequency-based deep-brain stimulation device – the transcranial alternating current dynamic frequency stimulation (tacs) system

Houston, tx, jan. 23, 2024 (globe newswire) -- nexalin technology, inc. (the “company” or “nexalin”) (nasdaq: nxl; nxliw) today announced that the united states patent and trademark office (uspto) has awarded u.s. patent no. 11,872,397 relating to the company's non-invasive, frequency-based deep brain stimulation device.  the newly-issued patent, entitled “transcranial alternating current dynamic frequency stimulation (tacs) system,” covers the core technology utilized in the company's gen-3 system, a proprietary and advanced waveform device that is designed to treat patients in a painless and undetectable manner.
NXL Ratings Summary
NXL Quant Ranking